Founded in 1989, Lumira Ventures is a venture capital firm based in Toronto, Canada. The firm seeks to invest in companies innovative biotherapeutics, medical technologies, and consumer health solutions.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Congruence Therapeutics | 08-Feb-2022 | Seed Round | 0000 | Drug Discovery | Startup | |
00000000 000000000 | 16-Dec-2021 | 0000 00000 | Biotechnology | Pre-Clinical Trials | 000000 0é00 00 | |
0000000 0000000000 | 08-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000000 00000000 00.0 |
0000 00000000000 | 16-Nov-2021 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000000 00000000 00.0 |
000000 00000000000 | 03-Nov-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 00000000 00000000 00.0 |
000000 00000000000 | 02-Nov-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000000 00000000 00.0 |
00000 | 24-Oct-2021 | 0000 00000 | 00.000 | Biotechnology | Pre-Clinical Trials | 00000 00000 |
000 000000000000 | 10-Aug-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 000000 0é00 00 |
BioTheryX | 21-May-2021 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | |
Antios Therapeutics | 09-Apr-2021 | Early Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 00000000 00000000 00.0 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Gladius Pharmaceuticals | 03-May-2022 | Out of Business | |
0000000 0000000 | 01-Feb-2021 | 000000000 00000000 | |
0000000 | 01-Feb-2021 | 000000000 00000000 | |
00000 00000000 | 23-Dec-2020 | 0000000 000000 | |
000000000 | 22-Oct-2020 | 000 00 00000000 | |
0000000 | 21-Sep-2020 | 000000000000000000 | |
000000 00000000000 | 26-Jun-2020 | 000 | 00000 |
000000 00000000000 | 05-Jun-2020 | 000000000000000000 | 00000 |
Satsuma Pharmaceuticals | 13-Sep-2019 | IPO | 000.00 |
Essa Pharma | 23-Aug-2019 | Public Investment 2nd Offering | 0000 |
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Lumira Ventures‘s full profile, request access.
Request a free trialInvestments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Vasco Larcina | Chief Financial Officer | Toronto, Canada | |||
Benjamin Rovinski Ph.D | Managing Director | 00 | 0 | 0 | Toronto, Canada |
Daniel Hétu MD | Managing Director | 00 | 0 | 0 | Montreal, Canada |
Gerry Brunk | Managing Director | 00 | 0 | 0 | Waltham, MA |
Peter van der Velden | Managing General Partner | 00 | 0 | 0 | Toronto, Canada |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Alexandria Venture Investments | 4 | 0 |
![]() |
![]() |
|
Aperture Venture Partners | 0 | 0 | 0 |
![]() |
![]() |
Delos Capital Partners | 0 | 0 |
![]() |
![]() |
|
EQT Life Sciences | 0 | 0 |
![]() |
![]() |
|
Fonds de solidarité FTQ | 0 | 0 |
![]() |
![]() |